Keyphrases
Normal Weight
100%
Obese Patients
100%
Clear Cell Renal Cell Carcinoma (ccRCC)
100%
Transcriptomic Signature
100%
Obesity Paradox
100%
Body Mass Index
87%
Peritumoral
87%
Memorials
75%
Adipose Tissue
62%
Cancer Genome Atlas
62%
COMPARZ
62%
Tumor
50%
Overweight Patient
50%
Overall Survival
37%
Primary Tumor
25%
Obesity
25%
Metastatic Renal Cell Carcinoma (mRCC)
25%
Nephrectomy
25%
Risk Score
25%
Transcriptomics
25%
Clinical Trials
12%
Clinical Data
12%
Young Investigators
12%
National Cancer Institute
12%
National Institutes of Health
12%
Research Services
12%
Gene Expression
12%
Prostate Cancer
12%
Clinical Significance
12%
Biological Mechanisms
12%
Microarray Data
12%
Angiogenesis
12%
Survival Benefit
12%
Angiogenic
12%
Inverse Association
12%
Gene Set Enrichment Analysis
12%
Oncological Outcomes
12%
Data Treatment
12%
Tumor Tissue
12%
Patient Relatives
12%
Phase III Clinical Trial
12%
Complex Interplay
12%
Demographic Data
12%
Tumor Microenvironment
12%
Survival Data
12%
Adipose Tissue Inflammation
12%
Treatment Initiation
12%
Index Assessment
12%
Novartis
12%
Weiss
12%
Clinical Cohort
12%
Gene Expression Differences
12%
Gene Set
12%
Immune Infiltration
12%
American Society of Clinical Oncology
12%
Tumor Immune Microenvironment
12%
Kidney Research
12%
Localized Renal Cell Carcinoma
12%
Overall Survival Analysis
12%
Research Fund
12%
Adipose Tissue Microenvironment
12%
Center Support
12%
Hallmark Genes
12%
Sidney
12%
Adipocytic Tumors
12%
Urological Cancer
12%
Intratumoral Fat
12%
Apparent Survival
12%
Medicine and Dentistry
Malignant Neoplasm
100%
Clear Cell Renal Cell Carcinoma
100%
Cohort Analysis
100%
Transcriptomics
100%
Body Mass Index
87%
Adipose Tissue
87%
Tumor
62%
Immunotherapy
50%
Overall Survival
50%
Clinical Trial
25%
Gene Expression
25%
Primary Tumor
25%
Nephrectomy
25%
Prostate Cancer
12%
Angiogenesis
12%
Kidney Metastasis
12%
Survival Analysis
12%
Tumor Microenvironment
12%
Genome-Wide Analysis of Gene Expression
12%
Clinical Oncology
12%
Immune Cell Infiltration
12%
Tumor Immune Microenvironment
12%
Urinary Tract Cancer
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Renal Cell Carcinoma
100%
Cohort Study
100%
Immunotherapy
50%
Overall Survival
50%
Clinical Trial
25%
Primary Tumor
25%
Inflammation
12%
Prostate Cancer
12%
Kidney Metastasis
12%
Tumor Microenvironment
12%
Urinary Tract Cancer
12%
Immunology and Microbiology
Adipose Tissue
100%
Body Mass
100%
Transcriptomics
100%
Immunotherapy
57%
Overall Survival
57%
Gene Expression
28%
Angiogenesis
14%
Immune Cell Infiltration
14%
Pretreatment
14%
Biochemistry, Genetics and Molecular Biology
Body Mass
100%
Cohort Study
100%
Transcriptomics
100%
Overall Survival
57%
Clinical Trial
28%
Gene Expression
28%
Angiogenesis
14%
Immunocompetent Cell
14%
Genome-Wide Analysis of Gene Expression
14%
Cell Infiltration
14%
Tumor Immune Microenvironment
14%